REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Palo Alto Investors LP's Holding History (CIK: 0001306923)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 1,611,787 Value ($000) $8,365 Avg Close — Range —
Q2 2024
Shares 5,257,086 Value ($000) $13,511 Avg Close — Range —
Q1 2024
Shares 5,248,004 Value ($000) $25,820 Avg Close — Range —
Q4 2023
Shares 5,237,284 Value ($000) $46,036 Avg Close — Range —
Q3 2023
Shares 5,228,609 Value ($000) $59,972 Avg Close — Range —
Q2 2023
Shares 5,228,609 Value ($000) $132,336 Avg Close — Range —
Q1 2023
Shares 5,270,209 Value ($000) $169,753 Avg Close — Range —
Q4 2022
Shares 5,283,609 Value ($000) $97,535 Avg Close — Range —
Q3 2022
Shares 4,405,039 Value ($000) $118,936 Avg Close — Range —
Q2 2022
Shares 4,405,039 Value ($000) $60,878 Avg Close — Range —
Q1 2022
Shares 4,415,689 Value ($000) $86,106 Avg Close — Range —
Q4 2021
Shares 4,369,366 Value ($000) $71,308 Avg Close — Range —
Q3 2021
Shares 3,201,866 Value ($000) $89,204 Avg Close — Range —
Q2 2021
Shares 3,201,866 Value ($000) $94,903 Avg Close — Range —
Q1 2021
Shares 3,201,866 Value ($000) $89,492 Avg Close — Range —
Q4 2020
Shares 2,673,313 Value ($000) $75,762 Avg Close — Range —
Q3 2020
Shares 1,994,905 Value ($000) $50,152 Avg Close — Range —
Q2 2020
Shares 1,704,372 Value ($000) $41,621 Avg Close — Range —
Q1 2020
Shares 615,705 Value ($000) $9,112 Avg Close — Range —
Q4 2019
Shares 88,590 Value ($000) $1,438 Avg Close — Range —
Q3 2014
Shares 80,369 Value ($000) $1,554 Avg Close — Range —
Q2 2014
Shares 91,669 Value ($000) $3,117 Avg Close — Range —
Q1 2014
Shares 91,669 Value ($000) $2,888 Avg Close — Range —